SurModics Total Liab from 2010 to 2025
| SRDX Stock | USD 30.38 0.40 1.33% |
Total Liabilities | First Reported 1998-03-31 | Previous Quarter 59.7 M | Current Value 52 M | Quarterly Volatility 19.3 M |
Check SurModics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SurModics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.5 M, Interest Expense of 4.3 M or Selling General Administrative of 68.6 M, as well as many indicators such as Price To Sales Ratio of 4.76, Dividend Yield of 0.0 or PTB Ratio of 5.67. SurModics financial statements analysis is a perfect complement when working with SurModics Valuation or Volatility modules.
SurModics | Total Liab |
Latest SurModics' Total Liab Growth Pattern
Below is the plot of the Total Liab of SurModics over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. SurModics' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SurModics' overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
SurModics Total Liab Regression Statistics
| Arithmetic Mean | 36,509,827 | |
| Geometric Mean | 24,159,612 | |
| Coefficient Of Variation | 68.47 | |
| Mean Deviation | 21,576,974 | |
| Median | 37,708,000 | |
| Standard Deviation | 24,998,748 | |
| Sample Variance | 624.9T | |
| Range | 70.4M | |
| R-Value | 0.95 | |
| Mean Square Error | 63.3T | |
| R-Squared | 0.91 | |
| Slope | 4,996,607 | |
| Total Sum of Squares | 9374.1T |
SurModics Total Liab History
About SurModics Financial Statements
SurModics investors use historical fundamental indicators, such as SurModics' Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SurModics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 68.6 M | 72 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for SurModics Stock Analysis
When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.